The role of p53 tumor suppressor gene in human head and neck tumorigenesis

Acta Oto-Laryngologica, Supplement

Volumn , Issue 527, 1997, Pages 21-24

  Pavelic, Zlatko P ^a   Gluckman, Jack L ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

head and neck cancer; p53; tumorigenesis

Indexed keywords

CELL PROTEIN; ONCOPROTEIN; PROTEIN P53; VIRUS LARGE T ANTIGEN; VIRUS PROTEIN;

ARTICLE; CARCINOGENESIS; ENVIRONMENTAL EXPOSURE; GENE MUTATION; GENE OVEREXPRESSION; HEAD AND NECK CANCER; HETEROZYGOSITY LOSS; HUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TUMOR SUPPRESSOR GENE; GENETICS; HEAD AND NECK TUMOR; MUTATION; PREVALENCE; REVIEW; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; GENES, P53; HEAD AND NECK NEOPLASMS; HUMANS; MUTATION; PREVALENCE;

EID: 0030611170     PISSN: 03655237     EISSN: None     Source Type: Journal    
DOI: 10.3109/00016489709124028     Document Type: Article

References (41)

1. Parkin DM, Laara E, Muir CS. Estimates of the worldwide frequency of the sixteen major cancers in 1980. Int J Cancer 1988; 41: 184-97.
2. Boring CC, Squires TS, Tong T. Cancer statistics, 1993. Cancer J Clin 1993; 43: 7-26.
3. Klein G. The approaching era of the tumor suppressor genes. Science 1987; 238: 1539-45.
4. Seizinger BR, Breakefield XO. The role of "tumor suppressor" genes in neural tumors. Trends Neurosci 1990; 13: 3-6.
5. De Mars R. In: 23rd Annual Symposium on Fundamental Cancer Research, Baltimore: Williams and Wilkins, Baltimore 1970: 105-6.
6. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci 1971; 68: 820-3.
7. Cayenne WK, Dryja TP, Phillips RA et al. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 1983; 305: 779-84.
8. Li FP. Cancer families: human models of susceptibility to neoplasia. Cancer Res 1988; 48: 5381-6.
9. Malkin, D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250: 1233-1238.
10. Srivastava S, Zou Z, Pirollo K, Blattner W, Chang EH. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 1990; 348: 747-9.
11. Levine AJ. The p53 tumor suppressor gene and product. In: Levine AJ, Frank LM, eds. Tumor Suppressor Genes, the cell cycle and cancer. New York: Cold Spring Harbor Press 1992; pp. L59-79.
12. Bartek J, Bartkova J, Vojtesek B, et al. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 1991; 6: 1699-703.
13. Hollstein M, Sindransky D, Volgelstein B, Harris CC. P53 mutations in human cancers. Science 1991; 253: 49-53.
14. Field JK, Pavelic ZP, Spandidos DA, Stambrook PJ, Jones AS, Gluckman JL. The role of the p53 tumor suppressor gene in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1993; 119: 1118-22.
15. Brachman DG, Graves D, Bokes E, et al. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res 1992; 52: 4832-6.
16. Sakai E, Tsuchida N. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogene 1992; 7: 927-33.
17. Maestro R, Dolcetti R, Gasparoto D, et al. High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene 1992; 7: 1159-66.
18. Somers KD, Merrick MA, Lopez ME, Incognito LA, Schechter GL, Casey G. Frequent p53 mutations in head and neck cancer. Cancer Res 1992; 52: 5997-6000.
19. Fearon ER. Genetic alterations underlying colorectal tumorigenesis In: Levine AJ, Frank LM, eds. Tumor suppressor genes, the cell cycle and cancer. New York: Cold Spring Harbor Press, 1992: 119-36.
20. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-67.
21. Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991; 66: 589-600.
22. Nishisho I, Nakamura Y, Miyoshi Y, et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991; 253: 665-9.
23. Hollstein MC, Smits AM, Galiana C, et al. Amplification of epidermal growth factor receptor gene but no evidence of ras mutations in primary human esophageal cancers. Cancer Res 1988; 48: 5119-23.
24. Jiang W, Kahn SM, Guillem JG, Lu S-H, Weinstein IB. Rapid detection of ras oncogenes in human tumors: application to colon, esophageal, and gastric cancer. Oncogene 1989; 4: 923-8.
25. Hollstein MC, Metcalf RA, Welsh JA, Montesano R, Harris CC. Frequent mutation of the p53 gene in human esophageal cancer. Proc Natl Acad Sci USA 1990; 87: 9958-61.
26. Gusterson BA, Anbazhagan R, Warren W, et al. Expression of p53 in premalignant and malignant squamous epithelium. Oncogene 1991; 6: 1785-1789.
27. Boyle JO, Hakim J, Koch W, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 1993; 53: 4477-80.
28. Shim DM, Kim J, Ro JY, et al. Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 1994; 54: 321-6.
29. Pavelic ZP, Li Y-Q, Stambrook PJ, et al. Overexpression of p53 protein is common in premalignant head and neck lesions. Anticancer Res 1994; 14: 2259-66.
30. Li Y-Q, Pavelic ZP, Wang L-J, et al. Altered p53 in microdissected, metachronous, premalignant and malignant oral lesions from the same patients. J Clin Pathol Mol Pathol 1995; 48: M269-72.
31. Brachman DG, Graves D, Vokes E, et al. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res 1992; 52: 4832-4836.
32. Leonard HJ, Kearsley JH, Chenevix-Trench G, Hayward NK. Analysis of gene amplification in head-and-neck squamous-cell carcinomas. Int J Cancer 1991; 48: 511-5.
33. Lammie GA, Fantl V, Smith R, et al. 11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinoma and linked to BCL-1. Oncogene 1991; 6: 439-44.
34. Motokura T, Bloom T, Kim HG, et al. A novel cyclin encoded by a bcl-1 -linked candidate oncogene. Nature 1991; 350: 512-5.
35. Rosenberg CL, Kim HG, Shows TB, Kronenberg HM, Arnold A. Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors. Oncogene 1991; 6: 449-53.
36. Lane DP, Crawfore LV. T antigen is bound to a host protein in SV40 transformed cells. Nature 1979; 278: 261-3.
37. Linzer DIM, Maltzman W, Levine AJ. The SV40 a gene product is required for the production of a 54,000 MW cellular tumor antigen. Virology 1979; 98: 308-18.
38. Sarrow P, Mo YS Williams J, Levine AJ. Adenovirus E1B-58 kd tumor antigen and SV40 large T antigen are physically associated with the same 54 kd protein in transformed cells. Cell 1992; 28: 387-94.
39. Yew PR, Berk AJ. Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature 1992; 357: 82-5.
40. Zur Hausen H. Viruses in human cancer. Science 1991; 254: 1167-73.
41. Oliner JD, Kinzler KW, Melzer PS, George DL, Vogelstein B. Amplification of gene encoding a p53-as-sociated protein in human sarcoma. Nature 1992; 358: 80-5.